Name: | Description: | Size: | Format: | |
---|---|---|---|---|
366.38 KB | Adobe PDF |
Advisor(s)
Abstract(s)
BACKGROUND:
Heart failure (HF) is associated with cardiac autonomic denervation (AD), which can be non-invasively assessed by 123I-metaiodobenzylguanidine (123I-mIBG) scintigraphy and has prognostic implications. We aimed to study the relationship between myocardial contractility assessed by global longitudinal strain (GLS) and AD assessed by 123I-mIBG scintigraphy in advanced HF.
METHODS/RESULTS:
BETTER-HF is a prospective randomized clinical trial including HF patients (pts) submitted to cardiac resynchronization therapy (CRT) who are submitted to a clinical, echocardiographic, and scintigraphic assessment before and 6 months after CRT. 81 pts were included. An echocardiographic response (absolute increase in left ventricular ejection fraction ≥ 10%) was observed in 73.7% of pts. A higher baseline late heart-to-mediastinum ratio (HMR) was associated with a better echocardiographic response. There was a significant association between late HMR and GLS at baseline and 6 months. At baseline, GLS had an AUC of 0.715 for discrimination for a late HMR < 1.6. A GLS cut-off of - 9% maximized the likelihood of correctly classifying a pt as having severe AD (HMR < 1.6).
CONCLUSION:
Myocardial contractility as assessed by GLS is moderately correlated with AD as assessed by 123I-mIBG scintigraphy and has a good discrimination for the identification of severe cardiac denervation. GLS may allow for a more readily accessible estimation of the degree of AD in advanced HF pts.
Description
Keywords
HSM CAR 3-Iodobenzylguanidine Adult Aged Aged, 80 and over Autonomic Nervous System Diseases / diagnostic imaging Autonomic Nervous System Diseases / etiology Cardiac Resynchronization Therapy Female Male Humans Heart Failure / diagnostic imaging Heart Failure / physiopathology Heart Failure / therapy Middle Aged Radionuclide Imaging Radiopharmaceuticals Stroke Volume / physiology Ventricular Function, Left / physiology
Citation
J Nucl Cardiol. 2019 Jun;26(3):869-879.